Clinical Trial: Investigation of the Efficacy of a Probiotic Mixture in Moderate Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Mechanistic Trial

U.S., Sept. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07193927) titled 'Investigation of the Efficacy of a Probiotic Mixture in Moderate Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Mechanistic Trial' on Aug. 06.

Brief Summary: The goal of this clinical trial is to evaluate whether a specific probiotic mixture can improve liver health in adults with moderate metabolic dysfunction-associated steatotic liver disease (MASLD).

The main questions it aims to answer are:

Can the probiotics improve liver fat and stiffness as measured by non-invasive imaging (FibroScan(R) CAP and FAST scores)? Does the probiotic affect other health markers like cholesterol, blood sugar, inflammation, an...